MRCP UK

MRCP UK Welcome to MRCP UK – Your Trusted Study Hub! This group is dedicated to medical professionals preparing for the MRCP (UK) exams – Part 1, Part 2, and PACES.

Join thousands of like-minded candidates to share resources, ask questions.

Pemphigus Vulgaris (PV):• Intraepidermal blister (suprabasal).•     Mucosa commonly involved (oral lesions)• Fragile, fl...
23/09/2025

Pemphigus Vulgaris (PV):
• Intraepidermal blister (suprabasal).
• Mucosa commonly involved (oral lesions)
• Fragile, flaccid bullae that rupture easily → painful erosions.
• Positive Nikolsky sign
• Autoantibodies against desmoglein 1 & 3
• Histology: “Row of tombstones”
• DIF: Fish-net pattern of IgG & C3.
• More severe, requires systemic steroids + immunosuppressants (rituximab, azathioprine).

Bullous Pemphigoid (BP):
• Subepidermal blister (below basement ).
• Mucosa usually spared, skin lesions
• Tense bullae, rarely rupture ,less painful, often itchy.
• Negative Nikolsky sign
• Autoantibodies against BP180, BP230
• Histology: Subepidermal blister with eosinophils.
• DIF: Linear IgG & C3 along basement membrane.
• Better prognosis, often responds to topical/systemic steroids ± tetracyclines.

23/09/2025

The FDA approved Teprotumumab (Tepezza) in 2020 as the first treatment for Thyroid Eye Disease (Graves’ orbitopathy)

Works by targeting the IGF-1 receptor
Especially helpful for patients with eye bulging (proptosis) and other eye symptoms caused by Graves’ disease.

A real breakthrough for patients who previously had very limited options!

Causes of Pancytopenia
22/09/2025

Causes of Pancytopenia

Management of DIC
22/09/2025

Management of DIC

𝐀𝐧𝐭𝐢-𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧𝐢𝐬𝐦 𝐃𝐫𝐮𝐠𝐬 – 𝐂𝐥𝐚𝐬𝐬𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 & 𝐃𝐨𝐬𝐞𝐬𝟏. 𝐃𝐨𝐩𝐚𝐦𝐢𝐧𝐞 𝐏𝐫𝐞𝐜𝐮𝐫𝐬𝐨𝐫 • Levodopa + Carbidopa (Sinemet, Madopar) • Start:...
21/09/2025

𝐀𝐧𝐭𝐢-𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧𝐢𝐬𝐦 𝐃𝐫𝐮𝐠𝐬 – 𝐂𝐥𝐚𝐬𝐬𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 & 𝐃𝐨𝐬𝐞𝐬

𝟏. 𝐃𝐨𝐩𝐚𝐦𝐢𝐧𝐞 𝐏𝐫𝐞𝐜𝐮𝐫𝐬𝐨𝐫
• Levodopa + Carbidopa (Sinemet, Madopar)
• Start: 25/100 mg 3 times daily
• Usual: 300–800 mg/day of levodopa in divided doses
• Max: ~2000 mg/day levodopa
• 𝐌𝐨𝐬𝐭 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐛𝐮𝐭 𝐥𝐨𝐧𝐠-𝐭𝐞𝐫𝐦 𝐮𝐬𝐞 lead 𝐝𝐲𝐬𝐤𝐢𝐧𝐞𝐬𝐢𝐚𝐬, 𝐦𝐨𝐭𝐨𝐫 𝐟𝐥𝐮𝐜𝐭𝐮𝐚𝐭𝐢𝐨𝐧𝐬

𝟐. 𝐃𝐨𝐩𝐚𝐦𝐢𝐧𝐞 𝐀𝐠𝐨𝐧𝐢𝐬𝐭𝐬

𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐞 𝐝𝐨𝐩𝐚𝐦𝐢𝐧𝐞 𝐫𝐞𝐜𝐞𝐩𝐭𝐨𝐫𝐬 𝐝𝐢𝐫𝐞𝐜𝐭𝐥𝐲.
• Pramipexole: 0.125 mg TID → titrate up; usual 0.75–4.5 mg/day
• Ropinirole: 0.25 mg TID → up to 24 mg/day
• Rotigotine (patch): 2 mg/24 h → up to 16 mg/24 h
• Apomorphine (SC injection): 2–6 mg as rescue for “off” episodes
• 𝐒𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬: 𝐡𝐚𝐥𝐥𝐮𝐜𝐢𝐧𝐚𝐭𝐢𝐨𝐧𝐬, 𝐢𝐦𝐩𝐮𝐥𝐬𝐞-𝐜𝐨𝐧𝐭𝐫𝐨𝐥 𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬

21/09/2025

𝐊𝐞𝐲 𝐏𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞𝐬 𝐢𝐧 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐨𝐟 𝐏𝐚𝐫𝐤𝐢𝐧𝐬𝐨𝐧’𝐬 𝐃𝐢𝐬𝐞𝐚𝐬𝐞

𝟏. 𝐀𝐠𝐞 𝐚𝐧𝐝 𝐅𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥 𝐒𝐭𝐚𝐭𝐮𝐬 𝐌𝐚𝐭𝐭𝐞𝐫

• 𝐘𝐨𝐮𝐧𝐠𝐞𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 (

21/09/2025

Semaglutide in Diabetes vs Weight Loss

1. Type 2 Diabetes (T2DM)
• Brands:
Ozempic(injection, weekly)
Rybelsus (oral, daily)

• FDA Indication: Improve glycemic control in adults with T2DM

• Typical Doses (per FDA labeling):
• Ozempic: 0.25 mg → 0.5 mg → 1 mg → up to 2 mg weekly
• Rybelsus: 7 mg or 14 mg daily (max 14 mg)
• Main Focus: Lowering HbA1c, reducing CV risk, modest weight loss as secondary benefit

2. Obesity / Weight Management
• Brand: Wegovy (injection, weekly)
• FDA Indication: Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27 with comorbidity)

• Typical Doses (per FDA labeling):
• 0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg weekly (maintenance)
• Main Focus: Significant and sustained weight reduction

Key Point:
• Same drug (semaglutide), but different dosing schedules, maximum doses, and FDA indications.
• Ozempic (≤2 mg) → mainly for diabetes
• Wegovy (2.4 mg) → mainly for weight loss

⚠️ Disclaimer:
This post is for educational purposes only. It is not medical advice and does not replace consultation with a qualified healthcare provider. If you have questions about semaglutide, diabetes, or weight management, please discuss with your doctor or pharmacist.

20/09/2025

𝐀 𝐍𝐞𝐰 𝐍𝐚𝐬𝐚𝐥 𝐑𝐨𝐮𝐭𝐞 𝐟𝐨𝐫 𝐄𝐝𝐞𝐦𝐚 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭

Enbumyst (bumetanide nasal spray) has been FDA-approved as a novel nasal delivery option for treating edema associated with:
• Congestive heart failure
• Hepatic disease
• Renal disease (nephrotic syndrome)

𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧: 𝐀𝐝𝐮𝐥𝐭 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐟𝐥𝐮𝐢𝐝 𝐨𝐯𝐞𝐫𝐥𝐨𝐚𝐝 𝐰𝐡𝐨 𝐫𝐞𝐪𝐮𝐢𝐫𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐝𝐢𝐮𝐫𝐞𝐭𝐢𝐜 𝐭𝐡𝐞𝐫𝐚𝐩𝐲.

20/09/2025

Definition of Autism

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by:

1. Persistent deficits in social communication and social interaction across multiple contexts.

2.Restricted, repetitive patterns of behavior, interests, or activities.

Autism Spectrum Disorders (ASD)

According to the DSM-5, all previously separate conditions are now grouped under Autism Spectrum Disorder, including:
• Autistic Disorder (classic autism)
• Asperger’s Syndrome (milder form, no language/intellectual delay)
• Childhood Disintegrative Disorder
• Pervasive Developmental Disorder – Not Otherwise Specified (PDD-NOS)

Key Features
• Difficulty with eye contact, social reciprocity, understanding emotions
• Delayed or unusual speech/language development
• Repetitive behaviors (hand-flapping, lining up toys, rigid routines)
• Hyper- or hypo-reactivity to sensory input (sounds, textures, lights)

𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐋𝐚𝐝𝐝𝐞𝐫 𝐢𝐧 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐍𝐞𝐩𝐡𝐫𝐨𝐩𝐚𝐭𝐡𝐲1️⃣ 𝐅𝐢𝐫𝐬𝐭-𝐥𝐢𝐧𝐞 (𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧)ACE inhibitor or ARB (maximal tolerated dose)Indefini...
20/09/2025

𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐋𝐚𝐝𝐝𝐞𝐫 𝐢𝐧 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐍𝐞𝐩𝐡𝐫𝐨𝐩𝐚𝐭𝐡𝐲
1️⃣ 𝐅𝐢𝐫𝐬𝐭-𝐥𝐢𝐧𝐞 (𝐅𝐨𝐮𝐧𝐝𝐚𝐭𝐢𝐨𝐧)

ACE inhibitor or ARB (maximal tolerated dose)
Indefinite therapy
Monitor creatinine, potassium, and proteinuria

2️⃣ 𝐒𝐞𝐜𝐨𝐧𝐝-𝐥𝐢𝐧𝐞 (𝐀𝐝𝐝-𝐨𝐧 𝐢𝐟 𝐚𝐥𝐛𝐮𝐦𝐢𝐧𝐮𝐫𝐢𝐚 𝐩𝐞𝐫𝐬𝐢𝐬𝐭𝐬 ≥𝟑𝟎 𝐦𝐠/𝐠 𝐝𝐞𝐬𝐩𝐢𝐭𝐞 𝐀𝐂𝐄/𝐀𝐑𝐁)

a) SGLT2 inhibitors
b) Non-steroidal mineralocorticoid receptor antagonist (ns-MRA)

𝐚) 𝐒𝐆𝐋𝐓𝟐 𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬
Drugs: Empagliflozin, Dapagliflozin, Canagliflozin

𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:
Reduce albuminuria
Slow CKD progression
CV protection (↓HF & CV death)
Use if eGFR ≥20–25 mL/min (drug-specific cutoff).

𝐛) 𝐍𝐨𝐧-𝐬𝐭𝐞𝐫𝐨𝐢𝐝𝐚𝐥 𝐦𝐢𝐧𝐞𝐫𝐚𝐥𝐨𝐜𝐨𝐫𝐭𝐢𝐜𝐨𝐢𝐝 𝐫𝐞𝐜𝐞𝐩𝐭𝐨𝐫 𝐚𝐧𝐭𝐚𝐠𝐨𝐧𝐢𝐬𝐭 (𝐧𝐬-𝐌𝐑𝐀)

𝐅𝐢𝐧𝐞𝐫𝐞𝐧𝐨𝐧𝐞 (𝐩𝐫𝐞𝐟𝐞𝐫𝐫𝐞𝐝 𝐨𝐯𝐞𝐫 𝐬𝐩𝐢𝐫𝐨𝐧𝐨𝐥𝐚𝐜𝐭𝐨𝐧𝐞/𝐞𝐩𝐥𝐞𝐫𝐞𝐧𝐨𝐧𝐞 𝐢𝐧 𝐃𝐍).

𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:↓ proteinuria, CV and renal outcomes (FIDELIO & FIGARO trials).

Indicated if:
Persistent albuminuria despite ACE/ARB ± SGLT2i
eGFR ≥25 mL/min, K⁺

Address

Hofuf
36441

Alerts

Be the first to know and let us send you an email when MRCP UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share